Skip to main content
Top
Published in: Current Atherosclerosis Reports 6/2011

01-12-2011 | Nutrition (William S. Harris, Section Editor)

Dietary Guidelines for Americans 2010: Implications for Cardiovascular Disease

Authors: Michael R. Flock, Penny M. Kris-Etherton

Published in: Current Atherosclerosis Reports | Issue 6/2011

Login to get access

Abstract

The 2010 Dietary Guidelines for Americans (DGA) provides science-based advice to promote health and reduce risk of major chronic diseases by diet and physical activity. The primary emphasis is on food-based recommendations that meet energy and nutrient needs. The DGA is made in the context of a total diet designed to reduce the incidence and prevalence of overweight and obesity. In addition, the DGA also targets cardiovascular disease (CVD) risk reduction. DGA recommends nutrient-dense foods including fruits and vegetables, whole grains, low-fat dairy, lean protein foods including seafood, and vegetable oils. This dietary pattern beneficially affects blood lipids and other CVD risk factors. Foods and nutrients to limit include solid fats (saturated fatty acids, trans-fatty acids), dietary cholesterol, added sugars, refined grains, and sodium. Healthy dietary patterns that emphasize nutrient-dense foods will significantly benefit public health, in part, by reducing CVD risk.
Literature
1.
go back to reference U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans 2010 7th Edition. Washington, DC: US Government Printing Office, 2010. U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans 2010 7th Edition. Washington, DC: US Government Printing Office, 2010.
2.
go back to reference Jacobs Jr DR, Gallaher DD. Whole grain intake and cardiovascular disease: a review. Curr Atheroscler Rep. 2004;6:415–23.PubMedCrossRef Jacobs Jr DR, Gallaher DD. Whole grain intake and cardiovascular disease: a review. Curr Atheroscler Rep. 2004;6:415–23.PubMedCrossRef
3.
go back to reference Dauchet L, Amouyel P, Dallongeville J. Fruits, vegetables and coronary heart disease. Nat Rev Cardiol. 2009;6:599–608.PubMedCrossRef Dauchet L, Amouyel P, Dallongeville J. Fruits, vegetables and coronary heart disease. Nat Rev Cardiol. 2009;6:599–608.PubMedCrossRef
4.
go back to reference Van Horn L, McCoin M, Kris-Etherton PM, et al. The evidence for dietary prevention and treatment of cardiovascular disease. J Am Diet Assoc. 2008;108:287–331.PubMedCrossRef Van Horn L, McCoin M, Kris-Etherton PM, et al. The evidence for dietary prevention and treatment of cardiovascular disease. J Am Diet Assoc. 2008;108:287–331.PubMedCrossRef
5.
go back to reference Kelly SA, Summerbell CD, Brynes A, et al. Wholegrain cereals for coronary heart disease. Cochrane Database Syst Rev. 2007;CD005051. Kelly SA, Summerbell CD, Brynes A, et al. Wholegrain cereals for coronary heart disease. Cochrane Database Syst Rev. 2007;CD005051.
6.
go back to reference Slavin JL. Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc. 2008;108:1716–31.PubMedCrossRef Slavin JL. Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc. 2008;108:1716–31.PubMedCrossRef
7.
go back to reference Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.
8.
go back to reference Food labeling: health claims; soluble dietary fiber from certain foods and coronary heart disease. Interim final rule. Fed Regist. 2002;67:61773–83. Food labeling: health claims; soluble dietary fiber from certain foods and coronary heart disease. Interim final rule. Fed Regist. 2002;67:61773–83.
9.
go back to reference Harris K, Kris-Etherton P. Effects of whole grains on coronary heart disease risk. Curr Atheroscler Rep. 2010;12:368–76.PubMedCrossRef Harris K, Kris-Etherton P. Effects of whole grains on coronary heart disease risk. Curr Atheroscler Rep. 2010;12:368–76.PubMedCrossRef
10.
go back to reference Tholstrup T, Hoy CE, Andersen LN, et al. Does fat in milk, butter and cheese affect blood lipids and cholesterol differently? J Am Coll Nutr. 2004;23:169–76.PubMed Tholstrup T, Hoy CE, Andersen LN, et al. Does fat in milk, butter and cheese affect blood lipids and cholesterol differently? J Am Coll Nutr. 2004;23:169–76.PubMed
11.
go back to reference Kris-Etherton PM, Grieger JA, Hilpert KF, West SG. Milk products, dietary patterns and blood pressure management. J Am Coll Nutr. 2009;28 Suppl 1:103S–19S.PubMed Kris-Etherton PM, Grieger JA, Hilpert KF, West SG. Milk products, dietary patterns and blood pressure management. J Am Coll Nutr. 2009;28 Suppl 1:103S–19S.PubMed
12.
go back to reference Zemel MB. Mechanisms of dairy modulation of adiposity. J Nutr. 2003;133:252S–6S.PubMed Zemel MB. Mechanisms of dairy modulation of adiposity. J Nutr. 2003;133:252S–6S.PubMed
13.
go back to reference Ross AC, Manson JE, Abrams SA, et al. The 2011 dietary reference intakes for calcium and vitamin D: what dietetics practitioners need to know. J Am Diet Assoc. 2011;111:524–7.PubMedCrossRef Ross AC, Manson JE, Abrams SA, et al. The 2011 dietary reference intakes for calcium and vitamin D: what dietetics practitioners need to know. J Am Diet Assoc. 2011;111:524–7.PubMedCrossRef
14.
go back to reference Nadir MA, Szwejkowski BR, Witham MD. Vitamin D and cardiovascular prevention. Cardiovasc Ther. 2010;28:e5–e12.PubMedCrossRef Nadir MA, Szwejkowski BR, Witham MD. Vitamin D and cardiovascular prevention. Cardiovasc Ther. 2010;28:e5–e12.PubMedCrossRef
15.
go back to reference Beauchesne-Rondeau E, Gascon A, Bergeron J, Jacques H. Plasma lipids and lipoproteins in hypercholesterolemic men fed a lipid-lowering diet containing lean beef, lean fish, or poultry. Am J Clin Nutr. 2003;77:587–93.PubMed Beauchesne-Rondeau E, Gascon A, Bergeron J, Jacques H. Plasma lipids and lipoproteins in hypercholesterolemic men fed a lipid-lowering diet containing lean beef, lean fish, or poultry. Am J Clin Nutr. 2003;77:587–93.PubMed
16.
go back to reference Davidson MH, Hunninghake D, Maki KC, et al. Comparison of the effects of lean red meat vs lean white meat on serum lipid levels among free-living persons with hypercholesterolemia: a long-term, randomized clinical trial. Arch Intern Med. 1999;159:1331–8.PubMedCrossRef Davidson MH, Hunninghake D, Maki KC, et al. Comparison of the effects of lean red meat vs lean white meat on serum lipid levels among free-living persons with hypercholesterolemia: a long-term, randomized clinical trial. Arch Intern Med. 1999;159:1331–8.PubMedCrossRef
17.
go back to reference Micha R, Wallace SK, Mozaffarian D. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation. 2010;121:2271–83.PubMedCrossRef Micha R, Wallace SK, Mozaffarian D. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation. 2010;121:2271–83.PubMedCrossRef
18.
go back to reference • Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation. 2010;121:586–613. This special report by the AHA sets the goal of improving cardiovascular health of all Americans by 20% while reducing deaths from CVD and stroke by 20%. PubMedCrossRef • Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation. 2010;121:586–613. This special report by the AHA sets the goal of improving cardiovascular health of all Americans by 20% while reducing deaths from CVD and stroke by 20%. PubMedCrossRef
19.
go back to reference Food labeling: health claims; soy protein and coronary heart disease. Food and Drug Administration, HHS. Final rule. Fed Regist. 1999;64:57700–33. Food labeling: health claims; soy protein and coronary heart disease. Food and Drug Administration, HHS. Final rule. Fed Regist. 1999;64:57700–33.
20.
go back to reference Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med. 1995;333:276–82.PubMedCrossRef Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med. 1995;333:276–82.PubMedCrossRef
21.
go back to reference • Jenkins DJ, Mirrahimi A, Srichaikul K, et al. Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms. J Nutr. 2010;140:2302S–11S. The different types of soy protein influences serum cholesterol reduction is a novel finding in this analysis. PubMedCrossRef • Jenkins DJ, Mirrahimi A, Srichaikul K, et al. Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms. J Nutr. 2010;140:2302S–11S. The different types of soy protein influences serum cholesterol reduction is a novel finding in this analysis. PubMedCrossRef
22.
go back to reference Griel AE, Kris-Etherton PM. Tree nuts and the lipid profile: a review of clinical studies. Br J Nutr. 2006;96 Suppl 2:S68–78.PubMedCrossRef Griel AE, Kris-Etherton PM. Tree nuts and the lipid profile: a review of clinical studies. Br J Nutr. 2006;96 Suppl 2:S68–78.PubMedCrossRef
23.
go back to reference Mukuddem-Petersen J, Oosthuizen W, Jerling JC. A systematic review of the effects of nuts on blood lipid profiles in humans. J Nutr. 2005;135:2082–9.PubMed Mukuddem-Petersen J, Oosthuizen W, Jerling JC. A systematic review of the effects of nuts on blood lipid profiles in humans. J Nutr. 2005;135:2082–9.PubMed
24.
go back to reference • Sabate J, Oda K, Ros E. Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials. Arch Intern Med. 2010;170:821–7. This review of intervention trials identifies the benefits of nut intake on blood lipid levels and what factors modify the effects. PubMedCrossRef • Sabate J, Oda K, Ros E. Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials. Arch Intern Med. 2010;170:821–7. This review of intervention trials identifies the benefits of nut intake on blood lipid levels and what factors modify the effects. PubMedCrossRef
25.
26.
go back to reference •• Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006;296:1885–99. This is an excellent review of randomized controlled trials and large prospective studies assessing the benefits and risks of fish or fish oil intake. PubMedCrossRef •• Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006;296:1885–99. This is an excellent review of randomized controlled trials and large prospective studies assessing the benefits and risks of fish or fish oil intake. PubMedCrossRef
27.
go back to reference Geleijnse JM, Giltay EJ, Grobbee DE, et al. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens. 2002;20:1493–9.PubMedCrossRef Geleijnse JM, Giltay EJ, Grobbee DE, et al. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens. 2002;20:1493–9.PubMedCrossRef
28.
go back to reference Balk EM, Lichtenstein AH, Chung M, et al. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis. 2006;189:19–30.PubMedCrossRef Balk EM, Lichtenstein AH, Chung M, et al. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis. 2006;189:19–30.PubMedCrossRef
29.
go back to reference Mozaffarian D, Geelen A, Brouwer IA, et al. Effect of fish oil on heart rate in humans. Circulation. 2005;112:1945–52.PubMedCrossRef Mozaffarian D, Geelen A, Brouwer IA, et al. Effect of fish oil on heart rate in humans. Circulation. 2005;112:1945–52.PubMedCrossRef
30.
go back to reference Harris WS. n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997;65:1645S–54S.PubMed Harris WS. n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997;65:1645S–54S.PubMed
31.
go back to reference Skulas-Ray AC, West SG, Davidson MH, Kris-Etherton PM. Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia. Expert Opin Pharmacother. 2008;9:1237–48.PubMedCrossRef Skulas-Ray AC, West SG, Davidson MH, Kris-Etherton PM. Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia. Expert Opin Pharmacother. 2008;9:1237–48.PubMedCrossRef
32.
go back to reference Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747–57.PubMedCrossRef Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747–57.PubMedCrossRef
33.
go back to reference Miller M, Stone NJ, Ballantyne C, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123:2292–333.PubMedCrossRef Miller M, Stone NJ, Ballantyne C, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123:2292–333.PubMedCrossRef
34.
go back to reference Mozaffarian D, Shi P, Morris JS, et al. Mercury exposure and risk of cardiovascular disease in two U.S. cohorts. N Engl J Med. 2011;364:1116–25.PubMedCrossRef Mozaffarian D, Shi P, Morris JS, et al. Mercury exposure and risk of cardiovascular disease in two U.S. cohorts. N Engl J Med. 2011;364:1116–25.PubMedCrossRef
35.
go back to reference Harris W, Kris-Etherton P, Harris K. Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr Atheroscler Rep. 2008;10:503–9.PubMedCrossRef Harris W, Kris-Etherton P, Harris K. Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr Atheroscler Rep. 2008;10:503–9.PubMedCrossRef
36.
go back to reference Burr ML. Secondary prevention of CHD in UK men: the diet and reinfarction trial and its sequel. Proc Nutr Soc. 2007;66:9–15.PubMedCrossRef Burr ML. Secondary prevention of CHD in UK men: the diet and reinfarction trial and its sequel. Proc Nutr Soc. 2007;66:9–15.PubMedCrossRef
37.
go back to reference • Mozaffarian D, Micha R, Wallace S: Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2010;7:e1000252. This is a detailed review of randomized controlled trials assessing the cardiovascular benefit of replacing SFA with PUFA in the diet. PubMedCrossRef • Mozaffarian D, Micha R, Wallace S: Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2010;7:e1000252. This is a detailed review of randomized controlled trials assessing the cardiovascular benefit of replacing SFA with PUFA in the diet. PubMedCrossRef
38.
go back to reference Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb. 1992;12:911–9.PubMedCrossRef Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb. 1992;12:911–9.PubMedCrossRef
39.
go back to reference •• Skeaff CM, Miller J. Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomised controlled trials. Ann Nutr Metab. 2009;55:173–201. This comprehensive review thoroughly examines different fatty acids and coronary heart disease in both epidmiologic and clinical studies. It provides an up-to-date analysis of the association between different fatty acids and coronary heart disease events and/or mortality. PubMedCrossRef •• Skeaff CM, Miller J. Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomised controlled trials. Ann Nutr Metab. 2009;55:173–201. This comprehensive review thoroughly examines different fatty acids and coronary heart disease in both epidmiologic and clinical studies. It provides an up-to-date analysis of the association between different fatty acids and coronary heart disease events and/or mortality. PubMedCrossRef
40.
go back to reference Brouwer IA, Wanders AJ, Katan MB. Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans–a quantitative review. PLoS One. 2010;5:e9434.PubMedCrossRef Brouwer IA, Wanders AJ, Katan MB. Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans–a quantitative review. PLoS One. 2010;5:e9434.PubMedCrossRef
41.
go back to reference Berglund L, Lefevre M, Ginsberg HN, et al. Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states. Am J Clin Nutr. 2007;86:1611–20.PubMed Berglund L, Lefevre M, Ginsberg HN, et al. Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states. Am J Clin Nutr. 2007;86:1611–20.PubMed
42.
go back to reference Judd JT, Baer DJ, Clevidence BA, et al. Dietary cis and trans monounsaturated and saturated FA and plasma lipids and lipoproteins in men. Lipids. 2002;37:123–31.PubMedCrossRef Judd JT, Baer DJ, Clevidence BA, et al. Dietary cis and trans monounsaturated and saturated FA and plasma lipids and lipoproteins in men. Lipids. 2002;37:123–31.PubMedCrossRef
43.
go back to reference Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009;169:659–69.PubMedCrossRef Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009;169:659–69.PubMedCrossRef
44.
go back to reference Kromhout D, Menotti A, Bloemberg B, et al. Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study. Prev Med. 1995;24:308–15.PubMedCrossRef Kromhout D, Menotti A, Bloemberg B, et al. Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study. Prev Med. 1995;24:308–15.PubMedCrossRef
45.
go back to reference • Siri-Tarino PW, Sun Q, Hu FB, Krauss RM: Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr. 2010;91:535–46. This meta-analsis of prospective studies challenges the connection between SFA and CVD risk, reporting that no association exists between SFA and CVD risk. PubMedCrossRef • Siri-Tarino PW, Sun Q, Hu FB, Krauss RM: Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr. 2010;91:535–46. This meta-analsis of prospective studies challenges the connection between SFA and CVD risk, reporting that no association exists between SFA and CVD risk. PubMedCrossRef
46.
go back to reference Jakobsen MU, O’Reilly EJ, Heitmann BL, et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr. 2009;89:1425–32.PubMedCrossRef Jakobsen MU, O’Reilly EJ, Heitmann BL, et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr. 2009;89:1425–32.PubMedCrossRef
47.
go back to reference Rudel LL, Parks JS, Sawyer JK. Compared with dietary monounsaturated and saturated fat, polyunsaturated fat protects African green monkeys from coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol. 1995;15:2101–10.PubMedCrossRef Rudel LL, Parks JS, Sawyer JK. Compared with dietary monounsaturated and saturated fat, polyunsaturated fat protects African green monkeys from coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol. 1995;15:2101–10.PubMedCrossRef
48.
go back to reference Trumbo P, Schlicker S, Yates AA, Poos M. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J Am Diet Assoc. 2002;102:1621–30.PubMedCrossRef Trumbo P, Schlicker S, Yates AA, Poos M. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J Am Diet Assoc. 2002;102:1621–30.PubMedCrossRef
50.
go back to reference Institute of Medicine. Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate. Washington D.C.: Institute of Medicine; 2005. Institute of Medicine. Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate. Washington D.C.: Institute of Medicine; 2005.
51.
go back to reference Strazzullo P, D’Elia L, Kandala N-B, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ. 2009;339. Strazzullo P, D’Elia L, Kandala N-B, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ. 2009;339.
52.
go back to reference Institute of Medicine Strategies to Reduce Sodium Intake in the United States. Washington, DC: Institute of Medicine, 2010. Institute of Medicine Strategies to Reduce Sodium Intake in the United States. Washington, DC: Institute of Medicine, 2010.
53.
go back to reference Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336:1117–24.PubMedCrossRef Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336:1117–24.PubMedCrossRef
54.
go back to reference Hansel B, Thomas F, Pannier B, et al. Relationship between alcohol intake, health and social status and cardiovascular risk factors in the urban Paris-Ile-De-France Cohort: is the cardioprotective action of alcohol a myth? Eur J Clin Nutr. 2010;64:561–8.PubMedCrossRef Hansel B, Thomas F, Pannier B, et al. Relationship between alcohol intake, health and social status and cardiovascular risk factors in the urban Paris-Ile-De-France Cohort: is the cardioprotective action of alcohol a myth? Eur J Clin Nutr. 2010;64:561–8.PubMedCrossRef
Metadata
Title
Dietary Guidelines for Americans 2010: Implications for Cardiovascular Disease
Authors
Michael R. Flock
Penny M. Kris-Etherton
Publication date
01-12-2011
Publisher
Current Science Inc.
Published in
Current Atherosclerosis Reports / Issue 6/2011
Print ISSN: 1523-3804
Electronic ISSN: 1534-6242
DOI
https://doi.org/10.1007/s11883-011-0205-0

Other articles of this Issue 6/2011

Current Atherosclerosis Reports 6/2011 Go to the issue

Nutrition (William S. Harris, Section Editor)

Effects of Diet on High-Density Lipoprotein Cholesterol

Nutrition (William S. Harris, Section Editor)

Dietary Nitrates, Nitrites, and Cardiovascular Disease

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.